```html

Nasal Congestion (Acute Upper Respiratory Infection)

Overview

Nasal congestion, often described as a “stuffy nose,” is a hallmark symptom of an acute upper respiratory infection (URI). An acute URI is a short‑lasting infection of the nose, sinuses, pharynx, or larynx that usually resolves within 7–10 days. The infection triggers inflammation of the nasal passages, leading to swelling of the mucosa and excess mucus production, which together create the sensation of blockage.

Who it affects – Almost everyone experiences an acute URI at least once a year. Children under 5 years have the highest incidence (≈ 6–8 episodes per year), while adults average 2–4 episodes annually.<sup>1</sup> The condition is not limited by gender, ethnicity, or socioeconomic status, but certain populations—such as smokers, people with asthma, and those with weakened immune systems—are more prone to severe or prolonged congestion.

Prevalence – In the United States, acute URIs account for roughly 20 % of all outpatient visits and 1 % of emergency department visits each year, translating to > 150 million cases annually.<sup>2</sup> Seasonal peaks occur in fall and winter, coinciding with the spread of rhinoviruses, influenza, and respiratory syncytial virus (RSV).

Symptoms

While nasal congestion is the primary complaint, many patients experience a constellation of additional signs. Below is a comprehensive list with brief explanations.

Local (nasal & sinus) symptoms

• Stuffy or blocked nose: Feeling of reduced airflow, often worse when lying down.
• Rhinorrhea (runny nose): Clear, watery discharge early in the illness that may become thicker and colored.
• Sneezing: Reflex to clear irritants; typically frequent in the first 48 hours.
• Post‑nasal drip: Mucus draining down the throat, causing throat irritation or cough.
• Facial pressure or pain: Result of sinus mucosal swelling; may worsen with bending forward.
• Reduced sense of smell (anosmia) or taste: Transient loss due to mucus blockage.

General systemic symptoms

• Low‑grade fever (≤ 38.5 °C/101.3 °F): Common in viral URIs, especially in children.
• Headache: Often described as dull, frontal, or sinus‑related.
• Fatigue or malaise: Result of the body’s immune response.
• Sore throat: Irritation from post‑nasal drip or direct viral involvement.
• Cough: Usually dry at first, becoming productive as mucus settles.
• Ear fullness or mild hearing loss: Eustachian tube dysfunction secondary to congestion.

Red‑flag symptoms (possible complications)

• High fever (> 39 °C/102.2 °F) lasting > 48 hours
• Severe facial pain, swelling, or redness over sinuses
• Persistent cough with blood‑tinged sputum
• Difficulty breathing, wheezing, or chest pain
• Sudden loss of smell lasting > 2 weeks
• Neurological symptoms (confusion, severe headache, stiff neck)

Causes and Risk Factors

Primary infectious agents

• Viruses (≈ 90 %) – Rhinovirus, coronavirus (including common-cold strains), influenza A/B, RSV, parainfluenza, adenovirus, human metapneumovirus.
• Bacteria (≈ 10 %) – Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis; bacterial involvement is usually secondary, after viral damage.

Non‑infectious contributors

• Allergic rhinitis (pollen, dust mites, animal dander)
• Environmental irritants (tobacco smoke, strong odors, pollutants)
• Hormonal changes (pregnancy, menstrual cycle)
• Structural abnormalities (deviated septum, nasal polyps)

Risk factors that increase susceptibility

• Age: Children <5 years and elderly > 65 years have weaker mucosal immunity.
• Close contact settings: Schools, daycare centers, nursing homes.
• Smoking or exposure to second‑hand smoke: Damages ciliary function.
• Underlying chronic diseases: Asthma, COPD, diabetes, immunosuppression.
• Seasonality: Fall/winter peaks due to indoor crowding and lower humidity.

Diagnosis

Diagnosis of acute URI‑related nasal congestion is primarily clinical, based on history and physical examination.

Clinical assessment

1. History: Onset, duration, exposure to sick contacts, presence of fever, allergen exposure.
2. Physical exam:
   • Inspection of nasal mucosa (redness, swelling, purulent discharge).
   • Palpation of sinuses for tenderness.
   • Oropharyngeal exam for erythema or exudates.
   • Auscultation of lungs to rule out lower‑respiratory involvement.

When additional testing is warranted

• Rapid antigen or PCR tests for influenza or SARS‑CoV‑2 if systemic symptoms suggest these viruses.
• Complete blood count (CBC) – may show leukocytosis if bacterial superinfection is present.
• Sinus imaging (CT scan) – indicated only for suspected sinusitis lasting > 10 days, severe pain, or complications.
• Allergy testing – if symptoms are recurrent, especially without infection signs.

Treatment Options

Therapy targets symptom relief, reduction of inflammation, and prevention of bacterial complications. Most cases resolve without prescription medication.

Pharmacologic treatments

• Analgesics/Antipyretics – Acetaminophen or ibuprofen (200–400 mg every 4–6 h) for fever and headache.<sup>3</sup>
• Topical nasal decongestants – Oxymetazoline or phenylephrine (spray, max 3 days) to shrink swollen mucosa. Important: prolonged use can cause rebound congestion (rhinitis medicamentosa).
• Oral decongestants – Pseudoephedrine (60 mg every 4–6 h) or phenylephrine (10 mg every 4 h). Contraindicated in uncontrolled hypertension, glaucoma, or certain cardiac conditions.
• Intranasal corticosteroids – Fluticasone, budesonide, or mometasone (2 sprays each nostril once daily). Helpful for both viral inflammation and allergic component; safe for up to 2‑3 weeks.
• Antihistamines – First‑generation (diphenhydramine) or second‑generation (loratadine, cetirizine) if allergic triggers are identified.
• Saline irrigation – Isotonic or slightly hypertonic saline (2–3 × daily) via squeeze bottle or neti pot. Evidence shows reduction in symptom severity and duration.<sup>4</sup>
• Antibiotics – Not indicated for uncomplicated viral URIs. Reserve for confirmed bacterial sinusitis (persistent > 10 days, worsening after initial improvement, or high‑grade fever with purulent nasal discharge). Common regimens: amoxicillin‑clavulanate 875/125 mg BID for 5–7 days.

Non‑pharmacologic & procedural measures

• Humidified air – Use a cool‑mist humidifier or vaporizer for 30 min 2–3 times daily.
• Steam inhalation – Hot shower or bowl of hot water (towel draped) can loosen mucus.
• Positioning – Elevate head while sleeping to reduce nasal pooling.
• Nasopharyngeal suction (infants) – Gentle suction with a bulb syringe for clear airway.
• Procedural decongestion – In refractory cases, an otolaryngologist may perform nasal balloon sinuplasty, though this is rarely needed for acute URI.

Living with Nasal Congestion (Acute Upper Respiratory Infection)

Managing day‑to‑day symptoms can improve comfort and speed recovery.

Practical tips

• Stay hydrated: Aim for 2–3 L of fluid daily (water, herbal tea, broth). Hydration thins mucus.
• Use saline sprays before decongestant sprays to minimize irritation.
• Limit nasal blowing to gentle pats; forceful blowing can push mucus into sinuses.
• Eat “soft” foods while congested—soups, smoothies, yogurt—to avoid throat irritation.
• Avoid alcohol and caffeine if taking decongestants, as they may increase heart rate and blood pressure.
• Monitor symptoms with a simple diary (temperature, nasal discharge character, pain scores) to spot worsening patterns.
• Rest 7–9 hours nightly; short naps if needed.
• Hand hygiene: Wash hands with soap for ≥ 20 seconds after coughing, blowing nose, or touching surfaces.

When to consider follow‑up

If congestion persists beyond 10 days, becomes markedly worse after an initial improvement, or is accompanied by fever > 38.5 °C lasting > 48 h, schedule a visit with your primary‑care provider or an otolaryngologist.

Prevention

Because most acute URIs are contagious, prevention focuses on reducing exposure and strengthening local defenses.

• Vaccination: Annual influenza vaccine reduces flu‑related URIs; COVID‑19 vaccines also decrease severity of viral upper‑respiratory involvement.
• Hand hygiene: Alcohol‑based hand rubs (≥ 60 % ethanol) when soap not available.
• Respiratory etiquette: Cover mouth/nose with tissue or elbow when coughing/sneezing; discard tissues promptly.
• Avoid close contact with individuals who are sick, especially in crowded indoor settings.
• Environmental control: Use HEPA filters, keep indoor humidity between 40–60 % to limit viral survival.
• Smoking cessation: Improves mucociliary clearance.
• Allergy management: Regular use of intranasal steroids and avoidance of known allergens reduces baseline congestion.

Complications

Although most acute URIs resolve spontaneously, untreated or severe congestion can lead to secondary problems.

• Acute bacterial sinusitis – Occurs in ~5–10 % of viral URIs; may require antibiotics.
• Otitis media – Eustachian tube blockage leads to middle‑ear infection, especially in children.
• Lower respiratory infection – Spread to bronchi (bronchitis) or lungs (pneumonia), more common in the elderly or immunocompromised.
• Sleep disturbance – Chronic nasal blockage impairs quality of sleep, contributing to daytime fatigue and decreased immunity.
• Rhinitis medicamentosa – Rebound congestion from > 3‑day overuse of topical decongestants.
• Exacerbation of asthma or COPD – Nasal inflammation can trigger bronchospasm.

When to Seek Emergency Care

References

1. American Academy of Pediatrics. Upper Respiratory Tract Infections. 2022. https://www.aap.org
2. CDC. Common Colds: Fact Sheet. 2023. https://www.cdc.gov
3. Mayo Clinic. Acetaminophen (Oral Route) Dosage. 2024. https://www.mayoclinic.org
4. Harvey R, et al. Saline nasal irrigation for symptomatic relief of acute rhinosinusitis: a systematic review. J Otolaryngol Head Neck Surg. 2023;52:31.
5. NIH. Guidelines for the Management of Acute Bacterial Sinusitis. 2022. https://www.nih.gov
6. World Health Organization. Influenza (Seasonal) Fact Sheet. 2024. https://www.who.int

```